Randomised, blinded clinical study to assess the immunogenicity and reactogenicity of SB Biologicals' dTpa and DTPa vaccines and a commercial Td vaccine administered as a booster dose to healthy children 4 to 6 years old, previously vaccinated with four doses of SB Biologicals' DTPa vaccine in the first two years of life
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2006
At a glance
- Drugs Diphtheria-tetanus vaccine; DTaP vaccine; Pertussis acellular vaccine
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- 06 Nov 2006 New trial record.